Back

Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.

20 May 2023 (12:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome 2 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

6 More presentations in this session

Presentation thumbnail
Prognostic impact of hyperuricemia in chronic heart failure with reduced ejection fraction
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides
Presentation thumbnail
Cystatin C is better than creatine for prognostic evaluation in heart failure patients
Doctor F. Gerardo (Amadora, PT)
Abstract Slides
Presentation thumbnail
Comparison of the prognostic value of the 6-minute walk distance of patients with heart failure with and without sarcopenia
Ms A. Kashima (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Remote heart failure symptom assessment after myocardial infarction identifies patients at risk of death
Doctor D. Jenca (Prague, CZ)
Abstract Slides
Presentation thumbnail
Impact of genetic specialty referrals among patients with nonischemic cardiomyopathy and advanced heart failure
Doctor R. DiBlasio (New York, US)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome 2

The Event

Event poster

Heart Failure 2023

20 May 2023 12:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources